Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients

被引:70
|
作者
Green, Deanna M. [2 ]
McDougal, Kathryn E. [3 ]
Blackman, Scott M. [1 ]
Sosnay, Patrick R. [1 ]
Henderson, Lindsay B. [1 ]
Naughton, Kathleen M. [1 ]
Collaco, J. Michael [2 ]
Cutting, Garry R. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Sch Med, Div Pediat Resp Sci, Baltimore, MD USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; LUNG-DISEASE; GENETIC MODIFIERS; MORTALITY; CONSEQUENCES; REGULATOR; INFECTION; CHILDREN;
D O I
10.1186/1465-9921-11-140
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Lung infection by various organisms is a characteristic feature of cystic fibrosis (CF). CFTR genotype effects acquisition of Pseudomonas aeruginosa (Pa), however the effect on acquisition of other infectious organisms that frequently precede Pa is relatively unknown. Understanding the role of CFTR in the acquisition of organisms first detected in patients may help guide symptomatic and molecular-based treatment for CF. Methods: Lung infection, defined as a single positive respiratory tract culture, was assessed for 13 organisms in 1,381 individuals with CF. Subjects were divided by predicted CFTR function: 'Residual': carrying at least one partial function CFTR mutation (class IV or V) and 'Minimal' those who do not carry a partial function mutation. Kaplan-Meier estimates were created to assess CFTR effect on age of acquisition for each organism. Cox proportional hazard models were performed to control for possible cofactors. A separate Cox regression was used to determine whether defining infection with Pa, mucoid Pa or Aspergillus (Asp) using alternative criteria affected the results. The influence of severity of lung disease at the time of acquisition was evaluated using stratified Cox regression methods by lung disease categories. Results: Subjects with 'Minimal' CFTR function had a higher hazard than patients with 'Residual' function for acquisition of 9 of 13 organisms studied (HR ranging from 1.7 to 3.78 based on the organism studied). Subjects with minimal CFTR function acquired infection at a younger age than those with residual function for 12 of 13 organisms (p-values ranging: < 0.001 to 0.017). Minimal CFTR function also associated with younger age of infection when 3 alternative definitions of infection with Pa, mucoid Pa or Asp were employed. Risk of infection is correlated with CFTR function for 8 of 9 organisms in patients with good lung function (> 90%ile) but only 1 of 9 organisms in those with poorer lung function (< 50%ile). Conclusions: Residual CFTR function correlates with later onset of respiratory tract infection by a wide spectrum of organisms frequently cultured from CF patients. The protective effect conferred by residual CFTR function is diminished in CF patients with more advanced lung disease.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients
    Deanna M Green
    Kathryn E McDougal
    Scott M Blackman
    Patrick R Sosnay
    Lindsay B Henderson
    Kathleen M Naughton
    J Michael Collaco
    Garry R Cutting
    Respiratory Research, 11
  • [2] Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function
    Salvatore, Donatello
    Terlizzi, Vito
    Francalanci, Michela
    Taccetti, Giovanni
    Messore, Barbara
    Biglia, Carlotta
    Pisi, Giovanna
    Calderazzo, Maria Adelaide
    Caloiero, Mimma
    Pizzamiglio, Giovanna
    Majo, Fabio
    Cresta, Federico
    Leonetti, Giuseppina
    De Venuto, Domenica
    RESPIRATORY MEDICINE, 2020, 171
  • [3] RESIDUAL CFTR CHLORIDE CHANNEL FUNCTION IN CF PATIENTS CARRYING R117H MUTATIONS
    Bronsveld, I
    Vernooij, A.
    de Jonge, H.
    Bot, A.
    Dankert, J.
    de Rijke, Y.
    PEDIATRIC PULMONOLOGY, 2011, : 273 - 274
  • [4] CFTR mutations in Chechen CF patients
    Petrova, N. V.
    Kashirskaya, N. Y.
    Saydaeva, D. K.
    Polakov, A. V.
    Adyan, T.
    Simonova, O. I.
    Gorinova, J. V.
    Kondratyeva, E. I.
    Novoselova, O. G.
    Vasilyeva, T. A.
    Marakhonov, A.
    Bikanov, R. A.
    Ginter, E. K.
    Zinchenko, R. A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 1006 - 1006
  • [5] Identification and Characterization of CFTR Gene Mutations in Indian CF Patients
    Sharma, N.
    Singh, M.
    Kaur, G.
    Thapa, B. R.
    Prasad, R.
    ANNALS OF HUMAN GENETICS, 2009, 73 : 26 - 33
  • [6] CFTR screening does not identify all CFTR coding region mutations in CF patients
    Sheridan, M. B.
    Wang, N.
    Mogayzel, P. J.
    Cutting, G. R.
    PEDIATRIC PULMONOLOGY, 2007, : 267 - 267
  • [7] Improved detection of CFTR mutations in southern California Hispanic CF patients
    Wong, LJC
    Wang, JJ
    Zhang, YH
    Hsu, E
    Heim, RA
    Bowman, CM
    Woo, MS
    HUMAN MUTATION, 2001, 18 (04) : 296 - 307
  • [8] Improved detection of CFTR mutations in Southern California Hispanic CF patients
    Wong, LJC
    Wang, JJ
    Zhang, YH
    Hsu, E
    Heim, RA
    Bowman, CM
    Woo, MS
    HUMAN MUTATION, 2002, 19 (01) : 79 - 79
  • [9] Mutations with Residual CFTR Function Are Associated to Better Glucose Tolerance and Insulin Secretion in Patients with Cystic Fibrosis
    Foppiani, Andrea
    Ciciriello, Fabiana
    Alghisi, Federico
    Lucidi, Vincenzina
    Sileo, Federica
    Lucanto, Maria Cristina
    Corti, Fabiola
    Colombo, Carla
    Battezzati, Alberto
    DIABETES, 2024, 73
  • [10] CFTR FUNCTION IN CF PATIENT-DERIVED AIRWAY CELLS WITH COMMON AND RARE MUTATIONS
    Illek, B.
    Zlock, L.
    Boecking, C.
    Green, B.
    Lefebvre, E.
    Bates, M.
    McGarry, M. E.
    Nielson, D. W.
    Finkbeiner, W. E.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 198 - 199